Altered Pharmacokinetics of Ceftazidime in Critically Ill Patients
Many critically ill patients have increased extracellular fluid which might affect ceftazidime pharmacokinetics. We investigated the pharmacokinetics of ceftazidime in 15 adult intensive care patients receiving 2 g of ceftazidime intravenously three times a day. The ceftazidime mean (standard deviat...
Enregistré dans:
| Publié dans: | Antimicrob Agents Chemother |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Microbiology (ASM)
1999
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89369/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10390248/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.7.1798 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
